Idun Biologics ApS
Private limited companyCVR 43750380AalborgActive
Idun Biologics ApS is a private limited company, based in Aalborg, active in manufacture of pharmaceutical preparations, founded in 2023. Equity was negative at the end of 2025 (−DKK 239k). The company made a loss in both 2024 and 2025, most recently DKK 85,011.
Key figures · financial year 2025
What has changed
calculated from recorded figures and datesFinancials: 2025 against 2024
- Gross profit fell 8% (2024 → 2025), to DKK 475k.
- The loss got smaller: from DKK 192k to DKK 85,011 (2024 → 2025).
Employees
- 1 more employees than a year earlier: 2 (07/2026) against 1 (07/2025).
Calculated from the latest two annual reports in sequence and from registrations in CVR. A figure that is missing in either year gives no line, and we derive no figures.
Financial statements
Financial years 2023–2025 · amounts in DKK thousandEquity and net profit
| 2023 | 2024 | 2025 | Change | |
|---|---|---|---|---|
| Revenue | not stated | not stated | not stated | – |
| Gross profit | 662 | 517 | 475 | −8% |
| Operating profit (EBIT) | −0 | −153 | −71 | +53.4% |
| Profit before tax | −3 | −158 | −74 | +53.4% |
| Net profit | −2 | −192 | −85 | +55.7% |
| Total assets | 117 | 834 | 1,256 | +50.6% |
| Equity | 38 | −154 | −239 | −55.1% |
| Liabilities | 80 | 988 | 1,495 | +51.3% |
| Cash and cash equivalents | 91 | 139 | 76 | −45.5% |
| Average number of employees | 0 | 1 | 1 | 0% |
Source: annual reports filed with the Danish Business Authority (XBRL). Figures for the company (not the group); change is the latest year against the year before. “–” means the figure is not stated in the annual report. Revenue is not stated for 2023, 2024, 2025: smaller companies may omit it, and we do not derive it from other figures.
Download the figures as CSV · free with an account, amounts in whole DKK
Signals from the financial statements
calculated from the 2025 figuresNegative equity
Equity was −DKK 239k at the end of 2025.
How is this calculated?
Equity in the latest annual report is below zero.
Loss for 3 years in a row
Net result has been negative in 2023–2025.
How is this calculated?
Net result is negative in the two or more latest annual reports in a row.
The signals are rules applied to the figures in the annual reports. They are not an assessment or credit rating of the company. See Data and method.
Annual reports
3 financial years| Financial year | Period | Published | Figures for | Documents |
|---|---|---|---|---|
| 2025 | 01/01/2025 – 31/12/2025 | 23/06/2026 | The company | PDF not statedXBRL |
| 2024 | 01/01/2024 – 31/12/2024 | 08/07/2025 | The company | PDFXBRL |
| 2023 | 02/01/2023 – 31/12/2023 | 23/04/2024 | The company | PDFXBRL |
The figures from all the annual reports are shown on this page. The documents themselves (PDF and XBRL, the machine-readable edition) are downloaded with a Pro account: sign in or create a free account, and then choose Pro. XBRL is the edition the figures on the page are read from.
Employees
monthly figures from CVRPosition in the industry
59 companies in the databaseComparison with the other companies in manufacture of pharmaceutical preparations based on the latest financial year.
Industry median: gross profit DKK 2.8m, net profit −DKK 2.2m, equity DKK 5.2m, 10 employees.
Compared with similar companies
size, age and company form| Group | Gross profit | Equity |
|---|---|---|
| Companies with fewer than 20 employees69,967 companies in the comparison | No. 54,689of 69,742 Better than 22% | No. 64,046of 69,964 Better than 8% |
| Same industry and fewer than 20 employees37 companies in the comparison | No. 14of 36 Better than 63% | No. 27of 37 Better than 28% |
| Companies that are founded within the last five years16,662 companies in the comparison | No. 12,144of 16,614 Better than 27% | No. 14,709of 16,661 Better than 12% |
| All companies of type ApS66,508 companies in the comparison | No. 52,620of 66,379 Better than 21% | No. 60,442of 66,505 Better than 9% |
The rank is calculated among companies in the database with a figure for the latest financial year, and is shown only for groups of at least ten companies.
Compare with the industry
Manufacture of pharmaceutical preparations- Idun Biologics ApSDKK 475k
- Novo Nordisk A/SDKK 250.3bn
- H. Lundbeck A/SDKK 20.4bn
- Idun Biologics ApS−DKK 85,011
- Novo Nordisk A/SDKK 102.4bn
- H. Lundbeck A/SDKK 3.2bn
- Idun Biologics ApS−DKK 239k
- Novo Nordisk A/SDKK 194bn
- H. Lundbeck A/SDKK 24.9bn
- Idun Biologics ApS2
- Novo Nordisk A/S27,279
- H. Lundbeck A/S2,261
Latest financial year per company. Choose up to three companies from the largest in the industry.
Owners and group
from the Public Ownership Register- Ymir Holdings ApS100%
Management
2 active registrationsExecutive management
| Name | Role | Appointed |
|---|---|---|
| Jens Frederik Teilfeldt Hansen | Director | 02/01/2023 |
| Clarisse Eve Chiche-Lapierre | Director | 02/01/2023 |
- Founders
- Ymir Holdings ApS
Signing rule: Selskabet tegnes af 2 direktører i forening.
Address and production units
1 active production unitsNy Kærvej 37
9000 Aalborg
| Production unit | Address | Employees | P number |
|---|---|---|---|
| Idun Biologics ApS | Ny Kærvej 37, 9000 Aalborg | 2 | 1028890458 |
Purpose
Selskabets formål er at udøve virksomhed med handel og service samt aktiviteter i tilknytning hertil.
The purpose is quoted from the register in Danish.
Changes year by year
7 registered events20261 changeaccounts 1
- AccountsAnnual report for 2025 published
20251 changeaccounts 1
- AccountsAnnual report for 2024 published
20241 changeaccounts 1
- AccountsAnnual report for 2023 published
20234 changesfounded 1 · management 2 · ownership 1
- FoundedRegistered as Idun Biologics ApS
- ManagementJens Frederik Teilfeldt Hansen appointed director
- ManagementClarisse Eve Chiche-Lapierre appointed director
- OwnershipYmir Holdings ApS registered as owner (100%)
Related companies
Largest in the industry
- Novo Nordisk A/SDKK 250.3bn
- H. Lundbeck A/SDKK 20.4bn
- Leo Pharma A/SDKK 8.2bn
- Alk-abelló A/SDKK 4.2bn
- Bavarian Nordic A/SDKK 3bn
- Pharmacosmos A/SDKK 1.6bn
Source and updates
The information comes from the Danish Central Business Register (Danish Business Authority) and from annual reports filed with the Danish Business Authority. Last synchronised 24/10/2026. The company is protected against advertising; contact details are not shown, and the data must not be used for marketing.